WHITEHOUSE STATION, N.J.--Merck, known as MSD outside the United States and Canada, today said a jury found in its favor in the Glynn v. Merck case in the U.S. District Court for the District of New ...

Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, according to recent data published in the Archives of Internal Medicine. Researchers from ...

WHITEHOUSE STATION, N.J., Oct. 4, 2010 - Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Alendronate, a drug commonly used to treat osteoporosis, ...

In re Fosamax (Alendronate Sodium), No. 11-5304, 08-08; U.S. District Court (DNJ); opinion by Pisano, U.S.D.J.; filed June 27, 2013. DDS No. 36-7-xxxx [17 pp.] Fosamax (Alendronate Sodium) is approved ...

Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD among postmenopausal women with T2D and osteoporosis. Romosozumab followed by alendronate treatment ...

Merck put Fosamax (alendronate sodium) and its $3 billion in total 2007 sales inits rear-view mirror yesterday, following the lapse of patent protection on theosteoporosis drug. Merck forecast that ...

We have written before about the Supreme Court’s impossibility preemption decision, Merck Sharpe & Dohme Corp. v. Albrecht, 139 S. Ct. 1668 (2019) (Albrecht) (here, here, here, and here), highlighting ...

(Reuters) - A federal appeals court on Wednesday revived claims by several hundred plaintiffs who accused Merck & Co of failing to adequately warn about the risks of thigh bone fractures associated ...

If alendronate 35 mg weekly is prescribed to maintain bone density, clinicians should also recommend supplemental calcium intake, such as 1,000–1,500 mg per day, and maintain serum vitamin 25OHD ...